Effective Treatment of Experimental Herpes Simplex Keratitis with New Derivative, 5-Methylamino-2′-Deoxyuridine (MADU)

Summary A recently synthesized compound, 5-methylamino-2′-deoxyuridine (MADU) was shown to be highly active in suppressing infection with herpes simplex virus in vitro and to exert beneficial effect in therapeutic and prophylactic-therapeutic treatment of experimental keratitis in the rabbit eye cau...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Experimental biology and medicine (Maywood, N.J.) N.J.), 1965-06, Vol.119 (2), p.515-520
Hauptverfasser: Nemes, Marjorie M., Hilleman, M. R.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 520
container_issue 2
container_start_page 515
container_title Experimental biology and medicine (Maywood, N.J.)
container_volume 119
creator Nemes, Marjorie M.
Hilleman, M. R.
description Summary A recently synthesized compound, 5-methylamino-2′-deoxyuridine (MADU) was shown to be highly active in suppressing infection with herpes simplex virus in vitro and to exert beneficial effect in therapeutic and prophylactic-therapeutic treatment of experimental keratitis in the rabbit eye caused by herpes simplex virus. The beneficial effect was equal to or only slightly less than that observed in comparative tests with 5-iodo-2′-deoxyuridine (IDU). The low toxicity of MADU for the rabbit eye, the high level of activity, the absence of halogen, and the apparent low level incorporation into the DNA of host cells justify experimental investigations in man in infections in which IDU would normally be employed. The practical and theoretical implications of use of MADU and IDU in the human being are discussed.
doi_str_mv 10.3181/00379727-119-30224
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_84144373</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.3181_00379727-119-30224</sage_id><sourcerecordid>84144373</sourcerecordid><originalsourceid>FETCH-LOGICAL-c341t-9c064e9d25d779b45d13228477405e7631638f0f29224a11682db372a853190c3</originalsourceid><addsrcrecordid>eNp9kMtO3DAUhq2qqAwDL9BF5VXVSjXjW-J4iZgBKm4LYG15kpNilBu2AzM7nolH4kmadKZix-roSN__S_-H0FdGDwXL2IxSobTiijCmiaCcy09owhKREJFq_RlNRoCMxC7aC-GBUpYonn5Bu0wKnmnBJ2i1KEvIo3sCfOvBxhqaiNsSL1YdeDd-tsJn4DsI-MbVXQUrfA7eRhddwM8u3uMreMbzAX6yY80vnJBLiPfrytauaQl_e3klc2hX6967wjWAf1weze9-7qOd0lYBDrZ3iu5OFrfHZ-Ti-vT38dEFyYVkkeicphJ0wZNCKb2UScEE55lUStIEVCpYKrKSllwP8y1jacaLpVDcZolgmuZiir5vejvfPvYQoqldyKGqbANtH0wmmZRCiQHkGzD3bQgeStMNAqxfG0bN6Nv8920G3-af7yH0bdveL2so3iNbwQMw2wDB_gHz0Pa-GdZ-VPkXZ3eILA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>84144373</pqid></control><display><type>article</type><title>Effective Treatment of Experimental Herpes Simplex Keratitis with New Derivative, 5-Methylamino-2′-Deoxyuridine (MADU)</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Nemes, Marjorie M. ; Hilleman, M. R.</creator><creatorcontrib>Nemes, Marjorie M. ; Hilleman, M. R.</creatorcontrib><description>Summary A recently synthesized compound, 5-methylamino-2′-deoxyuridine (MADU) was shown to be highly active in suppressing infection with herpes simplex virus in vitro and to exert beneficial effect in therapeutic and prophylactic-therapeutic treatment of experimental keratitis in the rabbit eye caused by herpes simplex virus. The beneficial effect was equal to or only slightly less than that observed in comparative tests with 5-iodo-2′-deoxyuridine (IDU). The low toxicity of MADU for the rabbit eye, the high level of activity, the absence of halogen, and the apparent low level incorporation into the DNA of host cells justify experimental investigations in man in infections in which IDU would normally be employed. The practical and theoretical implications of use of MADU and IDU in the human being are discussed.</description><identifier>ISSN: 0037-9727</identifier><identifier>ISSN: 1535-3702</identifier><identifier>EISSN: 1535-3699</identifier><identifier>DOI: 10.3181/00379727-119-30224</identifier><identifier>PMID: 14328932</identifier><language>eng</language><publisher>London, England: SAGE Publications</publisher><subject>Animals ; Antiviral Agents ; Deoxyuridine ; DNA ; Idoxuridine ; Keratitis ; Keratitis, Dendritic ; Keratitis, Herpetic ; Lagomorpha ; Nucleosides ; Old Medline ; Pharmacology ; Rabbits</subject><ispartof>Experimental biology and medicine (Maywood, N.J.), 1965-06, Vol.119 (2), p.515-520</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c341t-9c064e9d25d779b45d13228477405e7631638f0f29224a11682db372a853190c3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/14328932$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nemes, Marjorie M.</creatorcontrib><creatorcontrib>Hilleman, M. R.</creatorcontrib><title>Effective Treatment of Experimental Herpes Simplex Keratitis with New Derivative, 5-Methylamino-2′-Deoxyuridine (MADU)</title><title>Experimental biology and medicine (Maywood, N.J.)</title><addtitle>Proc Soc Exp Biol Med</addtitle><description>Summary A recently synthesized compound, 5-methylamino-2′-deoxyuridine (MADU) was shown to be highly active in suppressing infection with herpes simplex virus in vitro and to exert beneficial effect in therapeutic and prophylactic-therapeutic treatment of experimental keratitis in the rabbit eye caused by herpes simplex virus. The beneficial effect was equal to or only slightly less than that observed in comparative tests with 5-iodo-2′-deoxyuridine (IDU). The low toxicity of MADU for the rabbit eye, the high level of activity, the absence of halogen, and the apparent low level incorporation into the DNA of host cells justify experimental investigations in man in infections in which IDU would normally be employed. The practical and theoretical implications of use of MADU and IDU in the human being are discussed.</description><subject>Animals</subject><subject>Antiviral Agents</subject><subject>Deoxyuridine</subject><subject>DNA</subject><subject>Idoxuridine</subject><subject>Keratitis</subject><subject>Keratitis, Dendritic</subject><subject>Keratitis, Herpetic</subject><subject>Lagomorpha</subject><subject>Nucleosides</subject><subject>Old Medline</subject><subject>Pharmacology</subject><subject>Rabbits</subject><issn>0037-9727</issn><issn>1535-3702</issn><issn>1535-3699</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1965</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kMtO3DAUhq2qqAwDL9BF5VXVSjXjW-J4iZgBKm4LYG15kpNilBu2AzM7nolH4kmadKZix-roSN__S_-H0FdGDwXL2IxSobTiijCmiaCcy09owhKREJFq_RlNRoCMxC7aC-GBUpYonn5Bu0wKnmnBJ2i1KEvIo3sCfOvBxhqaiNsSL1YdeDd-tsJn4DsI-MbVXQUrfA7eRhddwM8u3uMreMbzAX6yY80vnJBLiPfrytauaQl_e3klc2hX6967wjWAf1weze9-7qOd0lYBDrZ3iu5OFrfHZ-Ti-vT38dEFyYVkkeicphJ0wZNCKb2UScEE55lUStIEVCpYKrKSllwP8y1jacaLpVDcZolgmuZiir5vejvfPvYQoqldyKGqbANtH0wmmZRCiQHkGzD3bQgeStMNAqxfG0bN6Nv8920G3-af7yH0bdveL2so3iNbwQMw2wDB_gHz0Pa-GdZ-VPkXZ3eILA</recordid><startdate>196506</startdate><enddate>196506</enddate><creator>Nemes, Marjorie M.</creator><creator>Hilleman, M. R.</creator><general>SAGE Publications</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>196506</creationdate><title>Effective Treatment of Experimental Herpes Simplex Keratitis with New Derivative, 5-Methylamino-2′-Deoxyuridine (MADU)</title><author>Nemes, Marjorie M. ; Hilleman, M. R.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c341t-9c064e9d25d779b45d13228477405e7631638f0f29224a11682db372a853190c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1965</creationdate><topic>Animals</topic><topic>Antiviral Agents</topic><topic>Deoxyuridine</topic><topic>DNA</topic><topic>Idoxuridine</topic><topic>Keratitis</topic><topic>Keratitis, Dendritic</topic><topic>Keratitis, Herpetic</topic><topic>Lagomorpha</topic><topic>Nucleosides</topic><topic>Old Medline</topic><topic>Pharmacology</topic><topic>Rabbits</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nemes, Marjorie M.</creatorcontrib><creatorcontrib>Hilleman, M. R.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Experimental biology and medicine (Maywood, N.J.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nemes, Marjorie M.</au><au>Hilleman, M. R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effective Treatment of Experimental Herpes Simplex Keratitis with New Derivative, 5-Methylamino-2′-Deoxyuridine (MADU)</atitle><jtitle>Experimental biology and medicine (Maywood, N.J.)</jtitle><addtitle>Proc Soc Exp Biol Med</addtitle><date>1965-06</date><risdate>1965</risdate><volume>119</volume><issue>2</issue><spage>515</spage><epage>520</epage><pages>515-520</pages><issn>0037-9727</issn><issn>1535-3702</issn><eissn>1535-3699</eissn><abstract>Summary A recently synthesized compound, 5-methylamino-2′-deoxyuridine (MADU) was shown to be highly active in suppressing infection with herpes simplex virus in vitro and to exert beneficial effect in therapeutic and prophylactic-therapeutic treatment of experimental keratitis in the rabbit eye caused by herpes simplex virus. The beneficial effect was equal to or only slightly less than that observed in comparative tests with 5-iodo-2′-deoxyuridine (IDU). The low toxicity of MADU for the rabbit eye, the high level of activity, the absence of halogen, and the apparent low level incorporation into the DNA of host cells justify experimental investigations in man in infections in which IDU would normally be employed. The practical and theoretical implications of use of MADU and IDU in the human being are discussed.</abstract><cop>London, England</cop><pub>SAGE Publications</pub><pmid>14328932</pmid><doi>10.3181/00379727-119-30224</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0037-9727
ispartof Experimental biology and medicine (Maywood, N.J.), 1965-06, Vol.119 (2), p.515-520
issn 0037-9727
1535-3702
1535-3699
language eng
recordid cdi_proquest_miscellaneous_84144373
source MEDLINE; Alma/SFX Local Collection
subjects Animals
Antiviral Agents
Deoxyuridine
DNA
Idoxuridine
Keratitis
Keratitis, Dendritic
Keratitis, Herpetic
Lagomorpha
Nucleosides
Old Medline
Pharmacology
Rabbits
title Effective Treatment of Experimental Herpes Simplex Keratitis with New Derivative, 5-Methylamino-2′-Deoxyuridine (MADU)
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T03%3A21%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effective%20Treatment%20of%20Experimental%20Herpes%20Simplex%20Keratitis%20with%20New%20Derivative,%205-Methylamino-2%E2%80%B2-Deoxyuridine%20(MADU)&rft.jtitle=Experimental%20biology%20and%20medicine%20(Maywood,%20N.J.)&rft.au=Nemes,%20Marjorie%20M.&rft.date=1965-06&rft.volume=119&rft.issue=2&rft.spage=515&rft.epage=520&rft.pages=515-520&rft.issn=0037-9727&rft.eissn=1535-3699&rft_id=info:doi/10.3181/00379727-119-30224&rft_dat=%3Cproquest_cross%3E84144373%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=84144373&rft_id=info:pmid/14328932&rft_sage_id=10.3181_00379727-119-30224&rfr_iscdi=true